Cell-free DNA: predictive tissue injury maps in COVID-19
CME and CMLE credits are not available for this program.
This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test.
Description:
In this webinar, we will review the application of cell-free DNA to define the sources of tissue injury that are associated with the different COVID-19 manifestations. We will also examine the tissue injury patterns to identify COVID-19 patients who will develop severe disease and complications
Learning Objectives:
- Describe the components of Cell-free DNA (cfDNA), and its dynamics in health and disease.
- Describe the utility of cell-free DNA to identify early stages of disease before clinical manifestations develop
- Identify challenges, and list possible solutions, unique to cfDNA assay validation.
- Discuss the unique advantages and disadvantages of alternate sources of cfDNA.
 |
 |
|---|---|
| Speaker: Sean Agbor-Enoh, MD, PhD |
Moderator: Marjorie Parker David, MD, MS |
- Click the "Enroll" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account by clicking here.
- Complete the "Demographic questionnaire for the "Utility of Cell-Free DNA in the Clinic Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME and CMLE credits are not available for this program.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation
